OXY One Step Oxycodone Rapid Test (Oral Fluid)
Rapid lateral flow immunoassay for the qualitative detection of oxycodone in oral fluid, used by healthcare professionals to screen for recent opioid exposure. CE Marked.
Product Description
The oxycodone assay is based on competitive binding in a lateral flow device. A solid-phase membrane carries oxycodone antibody and the matching drug-protein conjugate, with the antibody coupled to colloidal gold. Applied oral fluid migrates by capillary action and any oxycodone present competes with the conjugate for limited antibody binding sites. When enough drug is present it saturates the antibody, the conjugate is not captured at the test line, and the test line disappears — a missing test line is read as positive. In a negative sample a visible test line forms. A colored control line must appear in every valid run, confirming adequate specimen and proper membrane wicking.
Oxycodone is a semi-synthetic opioid structurally related to codeine and manufactured from thebaine, an alkaloid of the opium poppy. Like other opioid agonists it relieves pain by acting on opioid receptors in the spinal cord and brain, is prescribed for moderate to severe pain and is metabolized to oxymorphone and noroxycodone. Oral fluid testing indicates recent exposure, but interpretation should consider legitimate medication and clinical history. The test is a preliminary qualitative screen only; it does not measure concentration, timing or impairment. Presumptive positives require laboratory confirmation, and a physician should make the final diagnosis.
Specifications
| Product Name | Cat. No. | Specimen | Cut-off | Format |
|---|---|---|---|---|
| OXY Oxycodone | OXY-R02 | Oral Fluid | 40ng/ml | Device |
Send an Inquiry
Tell us the product and quantity you need. We will reply by email with pricing, packaging and availability for the OXY One Step Oxycodone Rapid Test (Oral Fluid).